Effect of the 2012 US Preventive Services Task Force Recommendations on Prostate-Specific Antigen Screening in a Medicare Advantage Population

*Center for the Evaluation of Value and Risk in Health (CEVR)

†Biostatistics, Epidemiology, and Research Design (BERD) Center, Institute for Clinical Research and Health Policy Studies (ICRHPS)

‡Department of Medicine, Tufts University School of Medicine, Boston, MA

§Division of Clinical Decision Making, Tufts Medical Center

All the authors are supported a research grant (19-02632) from Arnold Ventures (formerly, Laura and John Arnold Foundation). The funder had no role in the design or conduct of the study, analysis of the data, or the decision to submit the manuscript for publication.

Wong is a member of the US Preventive Services Task Force (USPSTF). This article does not necessarily represent the views and policies of the USPSTF.

The authors declare no conflict of interest.

Correspondence to: David D. Kim, PhD, Department of Medicine, Tufts University School of Medicine, Center for the Evaluation of Value and Risk in Health (CEVR), Institute for Clinical Research and Health Policy Studies (ICRHPS), Tufts Medical Center, 800 Washington Street, Box 063. Boston, MA 02111. E-mail: [email protected].

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.lww-medicalcare.com.

留言 (0)

沒有登入
gif